Power Training Combined With Interval Treadmill Training
PT³
1 other identifier
interventional
44
1 country
2
Brief Summary
Ambulatory children with cerebral palsy (CP) experience walking limitations which negatively influence their ability to physically participate in day to day life. The investigators propose that impaired muscle power generation is the key limiting factor affecting walking activity and participation. This proposal represents a combined approach where participants undergo resistance training for muscle power generation in combination with locomotor treadmill training that is based on typical pediatric walking and activity patterns rather than adult protocols, which are endurance or time-based. Therefore, the primary objective of this randomized controlled trial is to determine the effect of lower extremity Power Training combined with interval Treadmill Training (PT³) on functional walking capacity and community-based activity and participation in children with CP. We hypothesize that remediating the most pronounced muscle performance impairment (i.e., muscle power) with power training combined with a task- specific approach to walking that is developmentally appropriate will have a significant effect on walking capacity and performance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2019
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 1, 2018
CompletedFirst Posted
Study publicly available on registry
August 10, 2018
CompletedStudy Start
First participant enrolled
April 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 4, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 10, 2023
CompletedResults Posted
Study results publicly available
December 13, 2024
CompletedDecember 13, 2024
November 1, 2024
4.5 years
August 1, 2018
October 4, 2024
November 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in Self-selected Gait Speed (Normalized)
Calculated from the 10 meter walk test in meters/second at self-selected speed and then normalized by stature to yield non-dimensional units. Higher values represent faster gait speeds.
Baseline and immediate post training (8-10 weeks post baseline)
Change in Fast Gait Speed (Normalized)
Calculated from the 10 meter walk test in meters/second at fast walking speed and then normalized by stature to yield non-dimensional units. Higher values equal faster gait speeds.
Baseline and immediate post training (8-10 weeks post baseline)
Change in Peak Power
Lower extremity peak power produced during a power leg press test averaged over 5 trials; product of force x velocity; adjusted for sled angle and body mass
Baseline and immediate post training (8-10 weeks post baseline)
Change in Average Strides Per Day
Average number of strides walked per day captured by Step Watch accelerometer as worn for a minimum of 4 days
Baseline and immediate post training (8-10 weeks post baseline)
Secondary Outcomes (10)
Change in Self-selected Gait Speed (Normalized)
Baseline and 2 months post training (16 weeks post baseline)
Change in Fast Gait Speed (Normalized)
Baseline and 2 months post training (16 weeks post baseline)
Change in Peak Power
Baseline and 2 months post training (16 weeks post baseline)
Change in Average Strides Per Day
Baseline and 2 months post training (16 weeks post baseline)
Change in One Minute Walk Test
Baseline and immediate post training (8-10 weeks post baseline)
- +5 more secondary outcomes
Study Arms (2)
PT³
EXPERIMENTALPower Training combined with interval treadmill training
Traditional training
ACTIVE COMPARATORStrength training combined with traditional treadmill training
Interventions
Training will consist of unilateral and bilateral leg presses, targeting the quadriceps, hip extensors, and plantarflexors according to resistance training guidelines for muscle power training. The interval treadmill training portion will include short-bursts (30 seconds) of high speed walking intervals alternating with 30 seconds of low to moderate speed walking for a total of 30 minutes. Participants will train 3 x per week for 8 weeks. Total duration of each session will be approximately 1 hour.
Training will consist of unilateral and bilateral leg presses, targeting the quadriceps, hip extensors, and plantarflexors following the dosing and resistance training guidelines for muscle strength. Traditional treadmill training will consist of walking at steady-state speeds for 30 minutes. Participants will train 3 x per week for 8 weeks. Total duration of each session will be approximately 1 hour.
Eligibility Criteria
You may qualify if:
- Diagnosis of bilateral spastic Cerebral Palsy (CP)
- Age 10 to 17 years inclusive
- GMFCS levels I, II, or III
You may not qualify if:
- Orthopedic or neurosurgery less than 12 months prior to enrollment
- Injection therapies (phenol, botulinum toxin) less than 3 months prior to enrollment
- Lacking greater than 25 degrees of knee extension
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Louisiana State University Health Sciences Center
New Orleans, Louisiana, 70112, United States
Seattle Children's Hospital
Seattle, Washington, 98121, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Noelle G. Moreau
- Organization
- Louisiana State University Health Sciences Center - New Orleans
Study Officials
- PRINCIPAL INVESTIGATOR
Noelle G Moreau, PT, PhD
Louisiana State University Health Sciences Center - New Orleans
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 1, 2018
First Posted
August 10, 2018
Study Start
April 15, 2019
Primary Completion
October 4, 2023
Study Completion
November 10, 2023
Last Updated
December 13, 2024
Results First Posted
December 13, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share